Psoriatic Arthritis News and Research

RSS
Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.
Researchers who helped millions with arthritis receive Janssen Award

Researchers who helped millions with arthritis receive Janssen Award

Discovery of new genetic links to psoriasis

Discovery of new genetic links to psoriasis

Severe psoriasis linked to serious medical conditions including cardiovascular disease, depression and cancer

Severe psoriasis linked to serious medical conditions including cardiovascular disease, depression and cancer

Watery pools in bone marrow key to psoriatic arthritic damage

Watery pools in bone marrow key to psoriatic arthritic damage

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Enbrel shown to significantly reduced levels of C-reactive protein

Enbrel shown to significantly reduced levels of C-reactive protein

Severe psoriasis can cut short life

Severe psoriasis can cut short life

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Smoking linked to enduring risk of psoriasis

Smoking linked to enduring risk of psoriasis

Researchers shed light on the link between chronic inflammation and atherosclerosis

Researchers shed light on the link between chronic inflammation and atherosclerosis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott opens biotech facility in Puerto Rico

Abbott opens biotech facility in Puerto Rico

New Crohn's disease treatment Humira promises to reduce symptoms

New Crohn's disease treatment Humira promises to reduce symptoms

FDA approves Humira (adalimumab) for Crohn's disease

FDA approves Humira (adalimumab) for Crohn's disease

Remicade receives European approval for treatment of psoriatic arthritis

Remicade receives European approval for treatment of psoriatic arthritis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

Arthritis drug wins approval for use in children with Crohn's disease

Arthritis drug wins approval for use in children with Crohn's disease

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

Specific guidelines for treating juvenile idiopathic arthritis

Specific guidelines for treating juvenile idiopathic arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.